Technology Bundle ID
TAB-2586

Transgenic Mice Overexpressing Islet Beta Cell M3 Muscarinic Acetylcholine Receptors

Applications
Linked ID
E-455-2013-0
Lead Inventors
Jurgen Wess (NIDDK)
Development Status
In vivo data available (animal)
ICs
Researchers at NIH have generated transgenic mice in which the M3 muscarinic receptor is overexpressed in pancreatic beta cells. This was done by placing the receptor gene under the control of the 650 bp rat insulin promoter II (RIP II). The resulting mice show a pronounced increase in glucose tolerance and enhanced plasma insulin levels. Strikingly, these mutant mice were resistant to diet-induced glucose intolerance and hyperglycemia.
Commercial Applications
Diabetes research, especially type II Diabetes.
Competitive Advantages
These transgenic mice overexpress the M3 muscarinic acetylcholine receptor only in pancreatic beta cells but notably are resistant to diet-induced glucose intolerance and hyperglycemia

Request More Info

Licensing Contact: